While we found certain tumors to show strong or high rates of AR expression by immunohistochemical staining, the functionality of this hormone receptor in the ovarian cancers remains unknown; we have yet to determine if increased androgen exposure is a driver in tumor progression. Here, NR4A1 is linked to ovarian carcinoma.